Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
about
Molecular mechanisms of peritoneal dissemination in gastric cancerGenetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaRecent advances in the molecular diagnostics of gastric cancerIdentifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancerNRAGE promotes the malignant phenotype of hepatocellular carcinoma.Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.VEGF promotes gastric cancer development by upregulating CRMP4.The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomyCombined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems.An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.Inhibition of cell-adhesion protein DPYSL3 promotes metastasis of lung cancer.Integrated multigene expression panel to prognosticate patients with gastric cancer.A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer.
P2860
Q26738538-EEACF6BD-C65C-4F5D-9914-BE542600E12AQ26784412-3C9B8B22-E10C-4D4B-9D92-B98B5B69A893Q26785548-A2386EE9-B202-4277-BCEA-92EC9C79E750Q33837764-CD4774C0-E218-42BC-8E69-736B93F39D14Q34402115-67EFA82A-C0F6-4984-AD3D-A51AE4869335Q36640154-3157CC54-EE10-40E0-8261-F57AA784C2A7Q37046429-214BDA0A-E4F0-4DF5-8CE0-39CD29DD2154Q37086205-24631CC3-86F8-4115-873E-C1659BA909E7Q37588076-E1D97002-BE98-4438-978F-0C98A6879E8AQ38619155-4B64E7CE-941B-48CA-9969-1E56D6438998Q42378505-6E299E1E-F2AD-48C7-8A8A-83D8DA631B1CQ55158449-F9AB0876-3F14-4D4E-8007-3D8426A2B853Q55280375-757BBF8B-E712-44B1-8F7B-0202ED629425Q55322124-EBB3692D-033B-4DB6-BB82-AAC6E8CDAB62
P2860
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@ast
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@en
type
label
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@ast
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@en
prefLabel
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@ast
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@en
P2093
P2860
P1476
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
@en
P2093
Chie Tanaka
Dai Shimizu
Daisuke Kobayashi
Goro Nakayama
Hideki Takami
Hiroyuki Sugimoto
Hisaharu Oya
Masahiko Koike
Michitaka Fujiwara
Mitsuro Kanda
P2860
P2888
P356
10.1186/S13046-014-0066-9
P577
2014-08-06T00:00:00Z
P6179
1035913097